Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerChemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic AgentsA systems biology view of blood vessel growth and remodellingAntiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenograftsPentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targetsLong-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptideAnti-angiogenic peptides for cancer therapeuticsCecropinXJ, a silkworm antimicrobial peptide, induces cytoskeleton disruption in esophageal carcinoma cells.A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancerThe interconnectedness of cancer cell signaling.AntiAngioPred: A Server for Prediction of Anti-Angiogenic PeptidesSerpin-derived peptides are antiangiogenic and suppress breast tumor xenograft growthStructure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptidesCollagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.From antimicrobial to anticancer peptides. A review.Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesisSynergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.The War on Cancer rages on.Properdistatin inhibits angiogenesis and improves vascular function in human melanoma xenografts with low thrombospondin-1 expression.Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells.Collagen-mediated hemostasis.Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombospondin domain-containing proteins.Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models.
P2860
Q24628746-6CC979C8-E7FD-47F4-B075-FFCAD81A4797Q26830743-CD4193A9-996C-478B-8885-9ADE31F68880Q27003945-6928FFA2-FFC0-4115-B738-426923C8002EQ30855619-A124DF08-8F00-4DB8-9AEB-C926FD5BBB9FQ33528171-A8C1AD33-BCF1-4D23-BE4C-1BA7258D6BEAQ34504946-8F2B722C-7904-4C35-AD8E-FB0635115403Q34816580-C8691DA0-4D62-4E1A-AD1D-145B1AF1F025Q35043016-2C140908-CE56-4D30-B290-1E57D4F377F5Q35224948-3A07E291-C04D-4074-8A17-A1DAC2E6D760Q35407573-E6150196-36E8-401F-85EC-3767F330DC98Q35577780-F662C41F-786B-4D13-9157-B9400F83C791Q35669733-D061AF29-3438-4188-BA09-8F88DCCA8835Q35763338-41F558CF-065C-4036-A8DF-2450692F4CCCQ35882244-17AA7EEB-5F10-465D-93B8-2FB2AB15FECDQ36020002-956407B9-3283-4BCF-BA5D-B4CAE17B86BDQ36062996-DFB83F9A-29C6-4103-8076-3B6CDD41CF30Q37207728-86B8438E-B759-4444-8521-4B76E017C570Q37265743-D7711A8F-60AB-49FD-BB54-66B885B88935Q37401441-E07DDCE3-F1A6-4CA4-8019-6FC3E77D6FB7Q37478602-CB67298A-DC27-4355-B1F4-13661D847B92Q37718288-12CC6DFE-3E46-4E22-8727-CCE2BEF30461Q37845396-7A87C36A-881B-4473-9F7A-B10D18756FBDQ38015248-498D99D2-E217-4F1C-A1C2-9F07078D5035Q38691485-5310BBC1-B42C-4C10-B4F8-5B3187AD6680Q38733829-F58FB38B-BC74-4BF9-87EE-5946CEBDD288Q38974266-5F42010A-F811-4EDA-BA38-1D7DD3991ED1Q40444191-CE548C40-C8A8-4852-BE98-CB4472284FA5Q41828415-5DA19A8E-607D-4620-BB67-23D2AB66B13FQ49334226-6254151D-28BF-4E1F-9133-66C0DDD9CB3AQ50058491-09E58F0D-A424-4DF7-8B41-D6997E0C4290
P2860
Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peptides derived from type IV ...... -231 breast cancer xenografts.
@en
Peptides derived from type IV ...... -231 breast cancer xenografts.
@nl
type
label
Peptides derived from type IV ...... -231 breast cancer xenografts.
@en
Peptides derived from type IV ...... -231 breast cancer xenografts.
@nl
prefLabel
Peptides derived from type IV ...... -231 breast cancer xenografts.
@en
Peptides derived from type IV ...... -231 breast cancer xenografts.
@nl
P2093
P2860
P356
P1433
P1476
Peptides derived from type IV ...... -231 breast cancer xenografts.
@en
P2093
Aleksander S Popel
Elena V Rosca
Emmanouil D Karagiannis
Farhad Vesuna
Jacob E Koskimaki
Paul T Winnard
Venu Raman
Zaver M Bhujwalla
P2860
P304
P356
10.1593/NEO.09620
P577
2009-12-01T00:00:00Z